Zhejiang Cancer Hospital was issued ?°Qualification Certificate of Drug Clinical Trial Institution?± (certificate number: 0043) by State Food and Drug Administration (SFDA) On October 24, 2005.The Division of Oncology was accredited. On September 25, 2013 and March 6, 2017, the institution successfully passed the re-qualification inspection conducted by China Food and Drug Administration (CFDA). The phase I trial ward in institution was founded in 2018.
The clinical trial institution is responsible for clinical trials of phase I, II, III and IV anti-cancer drug trials, in-vitro diagnostic reagent, medical devices trials and Investigator- Initiated clinical Trials (IIT). Since establishment, the institution has undertaken more...
The biospecimen repository of our hospital was established in 2007, supported by special funds from the Health Commission of Zhejiang Province and provincial governor. The biospecimen repository is specialized in the collection, processing, storage, quality control, information improvement, ex warehouse and management of various biological samples. It also carries out biological sample research, provide sample quality control and production, and other technical services. The collected samples and information are open to the whole hospital, the whole province and the whole country. The building area of the biospecimen repository is more than 500 m2, with 8 full-time staff. More than 6 million yuan has been invested in all kinds of equipment to meet the basic needs of sample ......
Zhejiang Cancer Hospital is the Affiliated Cancer Hospital of Zhejiang Chinese Medical University. It undertakes the training of medical talents, which includes undergraduate clinical practice, graduate cultivation, standardized training of residents, continuing medical education and refresher training. In 2017, the hospital was approved as a national standardized training base for residents. It has 9 professional bases, which respectively are surgery, internal medicine, radiation oncology, anesthesiology, clinical pathology, medical laboratory, Radiology, ultrasound medicine and nuclear medicine, and enrolls more than 150 resident trainees annually. The hospital is listed as the "First Provincial Training Base" of the skills improvement project of the Surgical Base of the Institute of Hospital Management of the National Health Commission, the training base of Clinical pharmacists of the Chinese Medical Association, the training base of restricted medical technology of Zhejiang Province, the Training base of Chronic Disease Health Management-Cancer Screening and Early Diagnosis, and the Cardiovascular Emergency Training Center of the American Heart Association (AHA). Currently, the hospital and its institute have 173 graduate supervisors in total, including 55 doctoral supervisors. As 363 full-time graduate students were enrolled in 2022. we have more than 1,000 students and various trainees in the hospital at present. The hospital has formed a medical talent training system with a solid foundation, excellent specialties and broad disciplines.
Department of Cancer Prevention (formerly the Office of Zhejiang Cancer Center), also entitled Zhejiang Provincial Office for Cancer Prevention and Control (ZPOCPC), is affiliated to the Cancer Hospital of the University of Chinese Academy of Sciences (CHUCAS, Zhejiang Cancer Hospital).
Editorial Office of Oncology Journals The Editorial Office of Oncology Journals mainly edits and publishes two medical journals of oncology including China Cancer and Journal of Chinese Oncology. The Editorial Office was formerly known as the Information Office of Zhejiang Cancer Hospital. It was founded in July 1985 and renamed in June 2008.
